Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Endocannabinoid System as a Pharmacological Target for New Cancer Therapies
Robert Ramer, Felix Wittig, Burkhard Hinz
Cancers (2021) Vol. 13, Iss. 22, pp. 5701-5701
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Anandamide and other N-acylethanolamines: A class of signaling lipids with therapeutic opportunities
Elliot D. Mock, Berend Gagestein, Mario van der Stelt
Progress in Lipid Research (2022) Vol. 89, pp. 101194-101194
Open Access | Times Cited: 85
Combination treatment with FAAH inhibitors/URB597 and ferroptosis inducers significantly decreases the growth and metastasis of renal cell carcinoma cells via the PI3K-AKT signaling pathway
Junfeng Hao, Qiguang Chen, Yongmin Feng, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 4
Open Access | Times Cited: 24
Diacylglycerol lipase alpha promotes hepatocellular carcinoma progression and induces lenvatinib resistance by enhancing YAP activity
Yu‐Chuan Yan, Guang-Xiao Meng, Chuncheng Yang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 7
Open Access | Times Cited: 14
Effect of cannabinoids on the efficacy and side effects of anticancer therapeutic strategies – Current status of preclinical and clinical research
Robert Ramer, Burkhard Hinz
Pharmacology & Therapeutics (2025), pp. 108851-108851
Closed Access
The Combination of Δ9-Tetrahydrocannabinol and Cannabidiol Suppresses Mitochondrial Respiration of Human Glioblastoma Cells via Downregulation of Specific Respiratory Chain Proteins
Anne Rupprecht, Ulrike Theisen, Franziska Wendt, et al.
Cancers (2022) Vol. 14, Iss. 13, pp. 3129-3129
Open Access | Times Cited: 19
Two-Step Cell Death Induction by the New 2-Arachidonoyl Glycerol Analog and Its Modulation by Lysophosphatidylinositol in Human Breast Cancer Cells
Mikhail Akimov, N. M. Gretskaya, Evgenia I. Gorbacheva, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 820-820
Open Access
Carboxylesterase 1-mediated endocannabinoid metabolism in skin: role in melanoma progression in BRafV600E/Pten−/− mice
Veronika Morozova, Daniele Pellegata, Roch‐Philippe Charles, et al.
Cancer & Metabolism (2025) Vol. 13, Iss. 1
Open Access
Research mapping of cannabinoids and endocannabinoid system in cancer over the past three decades: insights from bibliometric analysis
Yaqian Tan, Hui Xia, Qi Song
Frontiers in Pharmacology (2025) Vol. 16
Open Access
The endocannabinoid system, a new gatekeeper in the pharmacology of human hepatocellular carcinoma
Nasim Ebrahimi, Nazanin Pazhouhesh Far, Siavash Seifollahy Fakhr, et al.
Environmental Research (2023) Vol. 228, pp. 115914-115914
Closed Access | Times Cited: 9
The Interaction of the Endocannabinoid Anandamide and Paracannabinoid Lysophosphatidylinositol during Cell Death Induction in Human Breast Cancer Cells
Mikhail Akimov, N. M. Gretskaya, Evgenia I. Gorbacheva, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2271-2271
Open Access | Times Cited: 3
Targeting the Endocannabinoidome in Pancreatic Cancer
Valerio Falasca, Marco Falasca
Biomolecules (2022) Vol. 12, Iss. 2, pp. 320-320
Open Access | Times Cited: 14
Cannabinoids and the endocannabinoid system in immunotherapy: helpful or harmful?
Arailym Sarsembayeva, Rudolf Schicho
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 8
Anticancer effect of minor phytocannabinoids in preclinical models of multiple myeloma
Cristina Aguzzi, Laura Zeppa, Maria Beatrice Morelli, et al.
BioFactors (2024)
Open Access | Times Cited: 2
Fluorescence-Based Enzyme Activity Assay: Ascertaining the Activity and Inhibition of Endocannabinoid Hydrolytic Enzymes
Pierangela Ciuffreda, Ornella Xynomilakis, Silvana Casati, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7693-7693
Open Access | Times Cited: 2
Supporting gut health with medicinal cannabis in people with advanced cancer: potential benefits and challenges
Hannah R. Wardill, Luke T. Wooley, Olivia M. Bellas, et al.
British Journal of Cancer (2023) Vol. 130, Iss. 1, pp. 19-30
Open Access | Times Cited: 6
Impact of Cannabinoid Compounds on Skin Cancer
Robert Ramer, Franziska Wendt, Felix Wittig, et al.
Cancers (2022) Vol. 14, Iss. 7, pp. 1769-1769
Open Access | Times Cited: 10
Inhibition of Monoacylglycerol Lipase Decreases Angiogenic Features of Endothelial Cells via Release of Tissue Inhibitor of Metalloproteinase-1 from Lung Cancer Cells
Felix Wittig, Lino Henkel, Jan Lukas Prüser, et al.
Cells (2023) Vol. 12, Iss. 13, pp. 1757-1757
Open Access | Times Cited: 4
Anandamide Inhibits Vascular Smooth Muscle Migration, Endothelial Adhesion Protein Expression and Monocyte Adhesion of Human Coronary Artery Cells
Elane Blessing, Elisa Teichmann, Burkhard Hinz
Cells (2024) Vol. 13, Iss. 24, pp. 2108-2108
Open Access | Times Cited: 1
Exploring the therapeutic potential of natural compounds modulating the endocannabinoid system in various diseases and disorders: review
Gidion Wilson, Lingling Yang, Xiaojuan Su, et al.
Pharmacological Reports (2023) Vol. 75, Iss. 6, pp. 1410-1444
Closed Access | Times Cited: 3
Lipid metabolism-derived FAAH is a sensitive marker for the prognosis and immunotherapy of osteosarcoma patients
Yanbin Shi, Song Wu, Xiaolin Zhang, et al.
Heliyon (2023) Vol. 10, Iss. 1, pp. e23499-e23499
Open Access | Times Cited: 3
Antiangiogenic Action of JZL184 on Endothelial Cells via Inhibition of VEGF Expression in Hypoxic Lung Cancer Cells
Felix Wittig, Liza Pannenberg, Rico Schwarz, et al.
Cells (2023) Vol. 12, Iss. 19, pp. 2332-2332
Open Access | Times Cited: 2
Cannabinoids as Prospective Anti-Cancer Drugs: Mechanism of Action in Healthy and Cancer Cells
Özge Boyacıoğlu, Petek Korkusuz
Advances in experimental medicine and biology (2022), pp. 145-169
Closed Access | Times Cited: 4
Effect of CB2 Stimulation on Gene Expression in Pediatric B-Acute Lymphoblastic Leukemia: New Possible Targets
Francesca Punzo, Maura Argenziano, Chiara Tortora, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8651-8651
Open Access | Times Cited: 3
Role of key endocannabinoids and their receptors in breast cancer
Mikhail Akimov, Polina V. Dudina, T. V. V’yunova, et al.
Reviews on Clinical Pharmacology and Drug Therapy (2024) Vol. 22, Iss. 1, pp. 41-51
Closed Access
TRIM21 Promotes Tumor Growth and Gemcitabine Resistance in Pancreatic Cancer by Inhibiting EPHX1‐Mediated Arachidonic Acid Metabolism
Xiaona Fan, Yisheng Dai, Chaohua Mo, et al.
Advanced Science (2024)
Open Access
Page 1 - Next Page

Scroll to top